Работы, цитирующие эту работу

Работ: 6

Работа: Unveiling the potential of CLL-1: a promising target for AML therapy

1. Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis

   Aziz Kubaev, Fadhil Faez Sead, Mohammad Pirouzbakht +6

   Обзорная статьяExtracellular vesicles in diseaseJournal of Liposome Research2025Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.109475

2. Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy

   Alireza Bayani, Munthar Kadhim Abosaoda, Jasur Rizaev +3

   Обзорная статьяAdvanced biosensing and bioanalysis techniquesClinical and Experimental Medicine2025Цитирований: 1

   ABIABI:AkademIndex/openalex/2025.review-article.000015

3. “Mesenchymal stem cell-derived exosomes (MSC-exosomes) in hematology: From mechanisms to clinical breakthroughs”

   Irfan Ahmad, Ahmed Hussein, Bhavesh Kanabar +8

   Обзорная статьяExtracellular vesicles in diseaseCellular Immunology2025Цитирований: 1

   ABIABI:AkademIndex/openalex/2025.review-article.000040

4. Targeting platelet-tumor cell interactions: a novel approach to cancer therapy

   Safia Obaidur Rab, Farag M. A. Altalbawy, Ashok Kumar Bishoyi +6

   Обзорная статьяInflammatory Biomarkers in Disease PrognosisMedical Oncology2025Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.065089

5. Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers

   Minzhi Huang, Ahmad Ewadi, Nazli Servatian +6

   Обзорная статьяCRISPR and Genetic EngineeringCritical Reviews in Oncology/Hematology2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000099

6. Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   СтатьяCAR-T cell therapy researchDiscover Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005310